Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2014


Pre-Filled Syringes Americas

31 Mar 2014 - 01 Apr 2014 - Iselin, NJ, USA



Bookmark and Share


Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

The importance of pre-filled syringes and injection devices have never been more pertinent, especially in the US. The challenges of finding a delivery method with patient centric design that avoids leaching, requires swift and decisive decisions early in the development process to avoid unnecessary costs and delays in development.

The SMi Group announces its Pre-Filled Syringes America Conference will be taking place in Iselin, New Jersey, USA, on the 31st March – 1st April 2014, where solutions to these challenges will be offered by many of the leading names in pharmaceuticals and medical device technologies.

Event’s website: http://www.smi-online.co.uk/2014pfs-usa30.asp  

Registration is now open. Over 85 delegates from the world’s leading Pharmaceutical and Biotechnology businesses will meet in New Jersey to discuss the latest achievements in the pre-filled syringe marketplace, developments in drug stabilisation and material interactions.

Benefits of attending:

• 3 days of presentations, panel discussions and an interactive workshop. Return to your business with the information and contacts to make the

right decisions for your products

• Focus sessions on biologics, manufacturing, polymers and extractables and leachables

• 20+ expert speakers from throughout the PFS and device ecosystem

• 85+ key decision makers, influencers and innovation drivers attending from the most relevant and sought after organisations in pre-filled syringes

• Network with delegates from the leading Biotechnology and Pharmaceutical businesses globally during the series of networking breaks, lunches and networking evenings designed to help conversation flow

• Hands on exhibition to help you evaluate the leading solutions in the marketplace and meet the thought leaders who developed them 

Key speakers include:

• Scott Brown, Device Development Lead, Merck 

• Alexei Goraltchouk, Senior Manager, Operations, Regeneron

• Stephen Barat, Senior Director, Toxicology and Operations, Forest Laboratories

• Steven Projan, SVP, MedImmune*

• Martin Dearden, Chief Corporate Microbiologist, UCB

• Thomas Osterberg, Senior Manager, Biologics, Pfizer Inc

• Greg Sacha, Senior Research Scientist, Baxter

• Christian Siegmund, Head of Prefilled Syringes and Liquid Vials, Roche

• Ravi S. Harapanhalli, Vice President, ParExel, and Former FDA Senior Executive

and many others.

For further information please contact Fateja Begum on +44 (0)20 7827 6184 or email: pharma@smiconferences.co.uk




Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!